Efficacy and tolerability of oral oxycodone and oxycodone/naloxone combination in opioid-naïve cancer patients: a propensity analysis

BACKGROUND: World Health Organization step III opioids are required to relieve moderate-to-severe cancer pain; constipation is one of the most frequent opioid-induced side effects. A fixed combination, prolonged-release oxycodone/naloxone (OXN), was developed with the aim of reducing opioid-related...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Drug Des Devel Ther
Главные авторы: Lazzari, Marzia, Greco, Maria Teresa, Marcassa, Claudio, Finocchi, Simona, Caldarulo, Clarissa, Corli, Oscar
Формат: Artigo
Язык:Inglês
Опубликовано: Dove Medical Press 2015
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4636087/
https://ncbi.nlm.nih.gov/pubmed/26586937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S92998
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы